Drugmakers prepare for the unusual: A defeat in Washington

“We’re ready to play ball, and I think that having big employers on board could do a lot for Democrats on pushing back on the narrative the pharmaceutical industry is going to push is that this is bad for the economy and bad for business,” said Shawn Gremminger, PBGHs director of health policy. “We think we could have a substantial role to play here.”

Read the article.